Skip to content

Clinical randomized double-blind placebo-controlled study of the efficacy of Bifidobacterium Lactobacillus M8 on cervical conization

Clinical randomized double-blind placebo-controlled study of the efficacy of Bifidobacterium Lactobacillus M8 on cervical conization

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017151
Enrollment
Unknown
Registered
2018-07-13
Start date
2018-08-01
Completion date
Unknown
Last updated
2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical intraepithelial neoplasia

Interventions

Group 1:Bifidobacterium Lactobacillus M8
Group 2:placebo

Sponsors

Weihai Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. aged 20~50 years old; 2. HPV screening in 1 months before the operation was positive for high-risk type; 3. conforms to WHO diagnostic criteria for cervical intraepithelial neoplasia; 4. HPV follow-up data were obtained from vaginal microecology results without vaginitis related treatment within 1 months before operation; 5. abstinence during the follow-up period; 6. informed and voluntarily participated in the study and signed informed consent (approved and approved by the hospital ethics committee).

Exclusion criteria

Exclusion criteria: 1. pregnant or lactation patients; 2. female patients who did not use any contraceptive measures; 3. unstable life signs and unstable patients; 4. combined with neurological, mental disorders, active malignancies, stroke, myocardial infarction and other serious primary diseases; 5. there were gastrointestinal bleeding, irritable bowel syndrome, Crohn disease or ulcerative colitis, and gastrointestinal tract history; 6. patients who took antibiotics, corticosteroids or other immunosuppressive agents, including probiotics, prebiotics, food and drugs in the past 1 months; 7. allergic reaction to the sample or obvious gastrointestinal symptoms such as intolerance; 8. patients received other clinical trials at the same time; 9. researchers who were identified by the researchers could not finish the research in time.

Design outcomes

Primary

MeasureTime frame
Vagina Microecology;

Countries

China

Contacts

Public ContactZhang Shihong

Weihai Municipal Hospital

jljack@126.com+86 18660377570

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026